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bypass in children
J. William Gaynor, MD
Improvements in the technology of cardiopulmonary bypass (CPB) havesignificantly reduced morbidity after repair of complex congenital heartdefects, even in very small neonates. Use of CPB, however, may exposeinfants to extremes of hemodilution and hypothermia, often in associationwith tissue ischemia, as well as initiate a systemic inflammatory responsewith significant accumulation of excess body water. Organ dysfunction
after CPB, especially the heart, lungs, and brain, may result in significant postop-
erative morbidity and mortality. A variety of techniques have been developed to
reverse the increase in total body water (TBW) after CPB, including ultrafiltration
during CPB, postoperative peritoneal dialysis, postoperative continuous arterio-
venous hemofiltration, and aggressive use of diuretics postoperatively. Ultrafiltra-
tion is a technique that removes plasma water and low molecular weight solutes by
a convective process using hydrostatic forces across a semipermeable membrane.
The composition of the ultrafiltrate is dependent on the pore size of the hemofilter.
Ultrafiltration was initially used during CPB, usually during rewarming (conven-
tional ultrafiltration or CUF). The volume of filtrate that can be removed during
CUF is restricted by the volume of the venous reservoir, and thus CUF provides only
a limited ability to remove excess water and reverse hemodilution.
Because of dissatisfaction with the ability of CUF to consistently prevent the
increase in TBW and reverse hemodilution after CPB in infants, Naik, Knight and
Elliott1,2 introduced a technique of ultrafiltration after separation from CPB, which
they termed modified ultrafiltration (MUF). In a preliminary study, they compared
the efficacy of no ultrafiltration, CUF, and MUF in preventing accumulation of
excess TBW.1 Changes in TBW were monitored by bioelectric impedance. The
volume of filtrate that could be removed during MUF was significantly greater than
during CUF. MUF significantly reduced the postoperative increase in TBW,
whereas results with CUF were no different from control. CUF did prevent the
increase in TBW in some patients; however, the response was neither uniform nor
reproducible. In a prospective randomized trial, MUF was shown to significantly
reduce the accumulation of TBW, decrease postoperative blood loss, and decrease
postoperative blood product use when compared with no ultrafiltration.2 Unexpect-
edly, MUF resulted in a significant increase in arterial blood pressure. In a subse-
quent study, MUF was shown to increase cardiac index and decrease pulmonary
vascular resistance with unchanged systemic vascular resistance. The hemodynamic
benefits of MUF correlated directly with increasing hematocrit value and thus the
degree of hemoconcentration.3
Since publication of these initial studies, there has been increasing interest in the
use of ultrafiltration both during and after CPB. A MEDLINE keyword search
identified 40 articles discussing MUF since 1995. Use of MUF has been shown to
decrease TBW accumulation, postoperative blood loss, and blood product use;
improve left ventricular systolic function, improve alveolar-arterial oxygen gradient
and lung compliance; decrease the frequency of pulmonary hypertensive episodes;
decrease the duration of postoperative ventilation; and decrease the incidence of
pleural effusions after cavopulmonary connection and the Fontan procedure.1-7
Despite these reports of beneficial efforts, there has been increasing confusion and
controversy concerning use of MUF. Much of this controversy stems from the lack
of a standard definition or method for MUF. In the initial report, MUF was
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performed in an arteriovenous fashion.1,2 After separation
from CPB, blood is withdrawn from the aortic cannula and
is passed through the hemofilter, and the concentrated blood
is returned to the right atrium. As fluid is removed from the
patient, the filling pressures decrease. Blood from the by-
pass circuit is concentrated with the filter and infused to
maintain intravascular volume. MUF thus provides the ca-
pability to remove excess water from the patient and salvage
blood from the bypass circuit. MUF is continued until the
hematocrit value is 40% or no blood remains in the bypass
circuit. Some studies have used venovenous MUF, in which
blood is withdrawn from the right atrium and returned to the
right atrium. No direct comparisons of the effectiveness of
arteriovenous MUF and venovenous MUF have been per-
formed. Journois and colleagues8 reported a modification of
CUF, which they termed zero-balance ultrafiltration, in
which ultrafiltration is performed during rewarming and the
filtrate is replaced by crystalloid solution to maintain reser-
voir volume while allowing continuous hemofiltration. Af-
ter separation from CPB, MUF is performed to reverse
hemodilution. A similar technique has been termed dilu-
tional ultrafiltration.6 In addition to differences in technique,
there has been significant variability in the criteria chosen
for termination of MUF. A survey of 22 institutes revealed
that 10 continued MUF until the circuit contents were
completely salvaged, 5 used a time-based criterion, 1 used a
hematocrit end point, 1 used a filtrate-volume end point, and
5 used other end points.9 The use of varying techniques and
end point criteria has made interpretation of published re-
sults difficult; nonetheless, the beneficial effects of MUF
have been independently reproduced at many institutions.
Concerns have been raised about potential risks and
complications of MUF.10,11 There was initial concern that
MUF would lead to hemodynamic instability by withdraw-
ing blood from the arterial cannula immediately after sep-
aration from CPB. Actually, the converse proved true and
MUF results in an increase in arterial blood pressure with
decreased filling pressures and improved cardiac perform-
ance. Multiple studies have demonstrated that concerns over
possible complications are primarily theoretical. In their
review of MUF at 22 centers, Darling and associates9 found
no reports of MUF-related morbidity or mortality.
The mechanisms by which MUF produces beneficial
effects have not been fully elucidated. Potential mecha-
nisms include reduction of tissue edema, hemoconcentra-
tion, and removal of inflammatory mediators. Initially,
MUF was hypothesized to improve organ function by sim-
ply reducing excess TBW and tissue edema.1,2 Studies of
the ultrafiltrate, however, demonstrated substantial amounts
of inflammatory mediators and vasoactive substances, in-
cluding interleukins 6, 8, and 10, tumor necrosis factor ,
and endothelin-1.6,8,11,12 One rationale for use of CUF and
zero-balance ultrafiltration is to initiate removal of media-
tors early in the inflammatory cascade and thus decrease the
severity of the inflammatory response.6,8 Although it is
tempting to speculate that removal of these mediators di-
minishes the inflammatory response to CPB, thus amelio-
rating some of the adverse sequelae, no study has yet
established a definite relationship between removal of in-
flammatory mediators and improved outcome. The positive
benefits of MUF, however, do correlate with the volume of
filtrate removed. In a carefully designed study, Daggett and
associates13 evaluated the effectiveness of no ultrafiltration,
CUF, and MUF in preventing tissue edema and organ dys-
function using a neonatal swine model of CPB. MUF was
more effective in preventing accumulation of TBW and
myocardial edema. MUF also resulted in a significant im-
provement in left ventricular contractility, assessed by the
preload recruitable stroke work index. Interestingly, reinfu-
sion of the filtrate resulted in depressed myocardial func-
tion, suggesting the filtrate does contain potentially toxic
factors. In a clinical study evaluating the effect of MUF on
left ventricular systolic function using load-independent
measures of myocardial performance, changes in left ven-
tricular systolic function were shown to correlate positively
with the degree of hemoconcentration. The concentration of
inflammatory mediators in the filtrate does not differ be-
tween CUF and MUF. However, because the volume of
filtrate removed is significantly greater with MUF, removal
of mediators is correspondingly greater.12 Thus, whether the
mechanism is reduction in TBW or removal of inflamma-
tory mediators, MUF is more effective then CUF because a
greater volume of filtrate can be removed.
In this issue of the Journal, Thompson and colleagues14
report results of a study comparing outcomes after CUF and
MUF when a standardized volume of fluid is removed. The
stated goal of the study was to determine whether “MUF has
any intrinsic benefit over CUF aside from the potentially
greater volume of fluid removed. . . .” The volume of filtrate
removed was arbitrarily set at 50% to 60% of the “effective
fluid balance,” defined as the priming volume plus volume
added during CPB, less the urine output. Despite the stan-
dardization of CPB, CUF patients received a significantly
larger priming volume and a larger volume was added
during CPB, even though the MUF patients were larger. The
reasons for the increased priming volume are unclear; how-
ever, it is likely that more volume was added during CPB to
maintain the reservoir level during CUF. Because of this
additional volume, a significantly greater volume of filtrate
was removed during CUF than during MUF (96 vs 69
mL/kg; P  .01). There was no difference in outcome
between the 2 groups. The study design suggests a misun-
derstanding of the rationale for MUF. MUF was introduced
to allow safe removal of a greater volume of fluid than
possible during CUF and thus more effectively prevent
accumulation of TBW, not because any special efficacy of
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ultrafiltration performed after separation from CPB. The
composition of the filtrate remains the same whether ultra-
filtration is performed during rewarming or a few minutes
later after separation from CPB. Indeed, one of the authors
of this study stated in a recent editorial that “modified
ultrafiltration filters the CPB perfusate in exactly the same
way as conventional ultrafiltration, except the filtration pro-
cess is performed after separation from cardiopulmonary
bypass.”10 The beneficial effects of MUF compared with
CUF are dependent on more aggressive fluid removal.
Therefore, a study design that limits the filtrate volume
during MUF predetermines the result. Unfortunately, this
study adds little useful information to the ongoing debate
concerning the optimal use of ultrafiltration during and after
CPB.
At The Children’s Hospital of Philadelphia, both CUF
and MUF are used in neonates and infants during and after
CPB, including those undergoing staged reconstruction for
hypoplastic left heart syndrome. In an 18-month period,
MUF was performed in 467 patients weighing less than 15
kg. The median age was 4 months and the median weight
was 5 kg. CUF was used in 87% of these patients. MUF is
continued until the circuit contents have been completely
salvaged. The mean volume of ultrafiltrate removed was
129  60 mL/kg. The filtrate volume was greater than 100
mL/kg in 65% of patients and greater than 150 mL/kg in
30%. The baseline hematocrit value was 38%  7% and
decreased to 25%  4% at the end of CPB. MUF resulted
in an increase to 40%  6%. The mean duration of MUF
was 12  3 minutes. There were no MUF-related compli-
cations.
Multiple studies have demonstrated that ultrafiltration,
both during and after CPB in children, is safe and reduces
postoperative morbidity, yet many important questions re-
main unresolved. It is important to recognize that CUF and
MUF are not competing, mutually exclusive techniques but
rather are complementary techniques with potentially addi-
tive positive effects. Filtration during CPB (CUF or zero-
balance ultrafiltration) may be used to remove inflammatory
mediators and vasoactive substances, whereas MUF is per-
formed after CPB to reverse hemodilution and decrease
tissue edema. The optimal use of ultrafiltration in children
undergoing repair of congenital heart defects will likely
result from a combined technique. The mechanisms by
which ultrafiltration results in improved organ function re-
quire additional investigation. As the technology and prac-
tice of CPB change with decreased use of hemodilution,
introduction of smaller circuits, and less use of hypothermia
and circulatory arrest, the indications for ultrafiltration are
likely to change as well. Further studies are necessary to
identify the patients most likely to benefit from ultrafiltra-
tion and to define the best protocols for the use of ultrafil-
tration in these patients.
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